Kyverna Therapeutics (KYTX) Change in Account Payables (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Change in Account Payables of $6.3 million for Q1 2026, up 803.48% on a QoQ basis from -$892000.0 in Q4 2025, and up 65.83% year-over-year from $3.8 million in Q1 2025.
Kyverna Therapeutics (KYTX) Change in Account Payables (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Change in Account Payables history runs 4 years deep, the most recent figure standing at $6.3 million for Q1 2026.
- Quarterly Change in Account Payables rose 65.83% year-over-year to $6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9000.0 (down 100.62% YoY) and the FY2025 annual result came in at -$2.5 million, down 439.67% from the prior year.
- Change in Account Payables was $6.3 million for Q1 2026 at Kyverna Therapeutics, up from -$892000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.3 million in Q1 2026 and bottomed at -$6.8 million in Q3 2025.
- A 4-year average of $661076.9 and a median of $509000.0 in 2023 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 2821.9% in 2024, while the deepest fall reached 528.78% in 2024.
- Kyverna Therapeutics' Change in Account Payables stood at $3.0 million in 2023, then tumbled by 277.84% to -$5.3 million in 2024, then surged by 83.16% to -$892000.0 in 2025, then surged by 803.48% to $6.3 million in 2026.
- Business Quant data shows KYTX's Change in Account Payables at $6.3 million in Q1 2026, -$892000.0 in Q4 2025, and -$6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Kyverna Therapeutics | 440.57 Mn | 440.57 Mn | - | 6.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.28 Mn |
| Mar 31, 2026 | 6.28 Mn |
| Dec 31, 2025 | -892,000.00 |
| Dec 31, 2025 | -892,000.00 |
| Sep 30, 2025 | -6.80 Mn |
| Sep 30, 2025 | -6.80 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 3.78 Mn |
| Mar 31, 2025 | 3.78 Mn |
| Dec 31, 2024 | -5.30 Mn |
| Dec 31, 2024 | -5.30 Mn |
| Sep 30, 2024 | 5.07 Mn |
| Sep 30, 2024 | 5.07 Mn |
| Jun 30, 2024 | -2.10 Mn |
| Jun 30, 2024 | -2.10 Mn |
| Mar 31, 2024 | 3.07 Mn |
| Mar 31, 2024 | 3.07 Mn |
| Dec 31, 2023 | 2.98 Mn |
| Dec 31, 2023 | 2.98 Mn |